HOUSE_OVERSIGHT_024858.jpg

1.29 MB
View Original

Extraction Summary

1
People
24
Organizations
0
Locations
1
Events
1
Relationships
3
Quotes

Document Information

Type: Market research report / financial analysis
File Size: 1.29 MB
Summary

A page from a Cowen market research report dated February 25, 2019, analyzing the CBD beverage market. The document includes data on price segmentation of various CBD beverage brands and demographic statistics regarding consumer usage based on a January 2019 survey. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a congressional investigation.

People (1)

Name Role Context
Michael Cella Recipient
Email address michael.cella@cowen.com appears in the sidebar watermark indicating the report is intended for him.

Organizations (24)

Name Type Context
Cowen
Cowen and Company
House Oversight Committee
CBD Living
Cannaki
Root Origins
Isodiol
Quantum
Aurora Elixers
Vybes
Endo Brands
Recess
Mountjoy
Diamond CBD
Kickback
CBD FX
Willie's
Cannabinoid Creations
EVERx Nutrition
Sprig
Hemp Bombs
GT's
Reliva
Rocky Mountain High

Timeline (1 events)

January 2019
Cowen Survey conducted with approximately 2500 participants regarding CBD usage.
N/A
Cowen Survey Respondents

Relationships (1)

Michael Cella Employee/Affiliate Cowen
Email address domain @cowen.com listed in watermark.

Key Quotes (3)

"There are a solid amount of beverage companies currently playing within the space, largely price positioned within the mainstream and value segments of the market."
Source
HOUSE_OVERSIGHT_024858.jpg
Quote #1
"Based on our survey, of respondents that use CBD, 19.2% use beverages as a form factor, which is admittedly higher than we would've expected given the nascent stage of the category."
Source
HOUSE_OVERSIGHT_024858.jpg
Quote #2
"This leaves us optimistic on the future prospects of the category as a waterfall effect can result in an increase in category mix."
Source
HOUSE_OVERSIGHT_024858.jpg
Quote #3

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document